Coloplast A/S - Coloplast completes the acquisition of Kerecis - Invitation for conference call on Monday, 4 September 2023 at 14.00-15.00 CEST

Monday, 4 September 2023 at 14.00 – 15.00 CESTIn connection with the completion of the acquisition of Kerecis, Coloplast will host a conference call with Fertram Sigurjonsson, Founder and CEO of Kerecis.A presentation will be available on Coloplast’s website before the conference call. The webcast of the conference call will be available during and after the event.

Coloplast will be represented by:Kristian Villumsen - President & CEOAnders Lonning-Skovgaard - Executive Vice President, CFOFertram Sigurjonsson - Founder and CEO of KerecisAleksandra Dimovska - Senior Director, Investor RelationsKristine Husted Munk - Senior Manager, Investor Relations

WebcastAny participants who do not wish to actively participate in the question & answer session, please access the conference call as a webcast directly by clicking here: Access the webcast

Dial-in detailsFor analysts and any participants wishing to actively participate in the question & answer session please sign up ahead of the conference call on the link below to receive an email with dial-in details: Register here

 

For more information, please contact:Aleksandra Dimovska - Senior Director, IR. Tel.: +45 4911 1800 / direct: +45 4911 2458. E-mail: dkadim@coloplast.comKristine Husted Munk - Senior Manager, IR. Tel.: +45 4911 1800 / direct: +45 4911 3266. E-mail: dkkhu@coloplast.comHannah K. Larsen - Coordinator & PA, IR. Tel.: +45 4911 1800 / direct: +45 4911 3616. E-mail: dkhakl@coloplast.com 

Coloplast will be available on individual phone lines after the conference call for further questions.

Attachment

  • Invitation for conf. call - Coloplast completes the acquisition of Kerecis - 4 September 2023 at 14.00 CEST
Coloplast AS (TG:CBHD)
Historical Stock Chart
Von Apr 2024 bis Mai 2024 Click Here for more Coloplast AS Charts.
Coloplast AS (TG:CBHD)
Historical Stock Chart
Von Mai 2023 bis Mai 2024 Click Here for more Coloplast AS Charts.